RD
Reese David M Vice-Président Exécutif, Recherche et Développement
Other M
Historial del iniciado Directivo Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Discover the complete record of transactions filed by Reese David M, Vice-Président Exécutif, Recherche et Développement. Officer active across 1 company, notably AMGEN INC. Cumulatively, 32 disclosures have been published. History available since 30 April 2021. The latest transaction was filed on 2 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Reese David M Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones 32 en total
● EVP & Chief Technology Officer · Directivos · 2 may 2026 · AMGEN INC 746 títulos @ 329,82 US$ 0.0001% mcap 2.3% de su flujo Common Stock SEC:0000318154-26-000067:0
● EVP & Chief Technology Officer · Directivos · 2 may 2026 · AMGEN INC 687 títulos @ 329,82 US$ 0.0001% mcap 2.1% de su flujo Common Stock SEC:0000318154-26-000067:1
● EVP & Chief Technology Officer · Directivos · 16 mar 2026 · AMGEN INC 6022 títulos @ 366,21 US$ 18.0% de su flujo Common Stock SEC:0000318154-26-000032:0
◆ EVP & Chief Technology Officer · Directivos · 3 mar 2026 · AMGEN INC 12.063 títulos 0Common Stock SEC:0000318154-26-000021:0
● EVP & Chief Technology Officer · Directivos · 11 nov 2025 · AMGEN INC 6490 títulos 0Common Stock SEC:0000318154-25-000080:0
◆ EVP & Chief Technology Officer · Directivos · 6 may 2025 · AMGEN INC 3549 títulos 0Common Stock SEC:0001127602-25-013786:0
● EVP & Chief Technology Officer · Directivos · 2 may 2025 · AMGEN INC 702 títulos @ 283,78 US$ 1.9% de su flujo Common Stock SEC:0001127602-25-013533:0
● EVP & Chief Technology Officer · Directivos · 2 may 2025 · AMGEN INC 665 títulos @ 283,78 US$ 1.8% de su flujo Common Stock SEC:0001127602-25-013533:1
● EVP & Chief Technology Officer · Directivos · 30 abr 2025 · AMGEN INC 768 títulos @ 288,56 US$ 2.1% de su flujo Common Stock SEC:0001127602-25-013286:0
● EVP & Chief Technology Officer · Directivos · 17 mar 2025 · AMGEN INC 3635 títulos @ 313,71 US$ 11.4% de su flujo Common Stock SEC:0001127602-25-010060:0
◆ EVP & Chief Technology Officer · Directivos · 3 mar 2025 · AMGEN INC 7277 títulos 0Common Stock SEC:0001127602-25-008428:0
◇ EVP & Chief Technology Officer · Directivos · 19 feb 2025 · AMGEN INC 8711 títulos @ 156,35 US$ 14.2% de su flujo Common Stock SEC:0001127602-25-006282:0
◆ EVP & Chief Technology Officer · Directivos · 7 may 2024 · AMGEN INC 3196 títulos 0Common Stock SEC:0001127602-24-014858:0
● EVP & Chief Technology Officer · Directivos · 5 may 2024 · AMGEN INC 633 títulos @ 311,29 US$ 2.0% de su flujo Common Stock SEC:0001127602-24-014512:0
● EVP & Chief Technology Officer · Directivos · 2 may 2024 · AMGEN INC 650 títulos @ 277,37 US$ 1.8% de su flujo Common Stock SEC:0001127602-24-014196:0
● EVP & Chief Technology Officer · Directivos · 30 abr 2024 · AMGEN INC 690 títulos @ 276,38 US$ 1.9% de su flujo Common Stock SEC:0001127602-24-013813:0
● EVP & Chief Technology Officer · Directivos · 18 mar 2024 · AMGEN INC 6202 títulos @ 268,87 US$ 16.6% de su flujo Common Stock SEC:0001127602-24-010858:0
◆ EVP & Chief Technology Officer · Directivos · 6 mar 2024 · AMGEN INC 12.407 títulos 0Common Stock SEC:0001127602-24-009247:0
● EVP, Research and Development · Directivos · 28 nov 2023 · AMGEN INC 165 títulos 0Common Stock SEC:0001127602-23-028437:0
● EVP, Research and Development · Directivos · 5 may 2023 · AMGEN INC 594 títulos @ 231,89 US$ 1.4% de su flujo Common Stock SEC:0001127602-23-015051:0
◆ EVP, Research and Development · Directivos · 2 may 2023 · AMGEN INC 3814 títulos 0Common Stock SEC:0001127602-23-014612:0
● EVP, Research and Development · Directivos · 30 abr 2023 · AMGEN INC 666 títulos @ 239,74 US$ 1.6% de su flujo Common Stock SEC:0001127602-23-014157:0
● EVP, Research and Development · Directivos · 17 mar 2023 · AMGEN INC 3978 títulos @ 234,57 US$ 9.6% de su flujo Common Stock SEC:0001127602-23-010922:0
◆ EVP, Research and Development · Directivos · 6 mar 2023 · AMGEN INC 7947 títulos 0Common Stock SEC:0001127602-23-009495:0
● EVP, Research and Development · Directivos · 2 nov 2022 · AMGEN INC 2440 títulos @ 272,06 US$ 7.3% de su flujo Common Stock SEC:0001127602-22-024930:0
25 de 32 declaraciones
Ver más (7 restantes) About Reese David M REESE DAVID M is Vice-Président Exécutif, Recherche et Développement. He has 32 filings in total, all with AMGEN INC, and the sampled recent filings cover the period from 2021-05-04 to 2026-05-05. The total buy amount and the total sell amount are both 0, and the most frequent transaction nature is Retenue fiscale.